Endometrial Cancer: A Society of Gynecologic Oncology Evidence-based Review and Recommendations, Part II
Overview
Authors
Affiliations
In 2014, the Society of Gynecologic Oncology's Clinical Practice Committee published a clinical update reviewing the treatment of women with endometrial cancer. At that time, there had been significant advances in the diagnosis, work-up, surgical management, and available treatment options allowing for more optimal care of affected women. This manuscript, Part II in a two-part series, includes specific recommendations on treatment of recurrent disease, post treatment surveillance and survivorship, considerations for younger women, and special situations. Part I covered histopathology and molecular pathology, risk factors, presentation and diagnostic approach, surgical approach and adjuvant therapy.
Agusti N, Kanbergs A, Nitecki R Gynecol Oncol. 2024; 185:121-127.
PMID: 38402734 PMC: 11275632. DOI: 10.1016/j.ygyno.2024.02.020.
Iliadis S, Gambadauro P Sci Rep. 2023; 13(1):5861.
PMID: 37041242 PMC: 10090158. DOI: 10.1038/s41598-023-32911-y.
Asami Y, Kato M, Hiranuma K, Matsuda M, Shimada Y, Ishikawa M Br J Cancer. 2023; 128(8):1582-1591.
PMID: 36797358 PMC: 10070437. DOI: 10.1038/s41416-023-02203-3.
Hagemann I, Bridge J, Tafe L, Hameed M, Moncur J, Bellizzi A Arch Pathol Lab Med. 2022; 147(10):1148-1157.
PMID: 36538387 PMC: 11062402. DOI: 10.5858/arpa.2022-0229-CP.
SEOM-GEICO clinical guidelines on endometrial cancer (2021).
Barretina-Ginesta M, Quindos M, Alarcon J, Esteban C, Gaba L, Gomez C Clin Transl Oncol. 2022; 24(4):625-634.
PMID: 35312947 PMC: 8986694. DOI: 10.1007/s12094-022-02799-7.